Old Web
English
Sign In
Acemap
>
authorDetail
>
Ana Almonte
Ana Almonte
Eisai
Internal medicine
Oncology
Medicine
Lenvatinib
open label
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
2021
Journal of Clinical Oncology
Lori J. Wirth
Marcia S. Brose
Eric J. Sherman
Lisa Licitra
Martin Schlumberger
Steven I. Sherman
Keith C. Bible
Bruce G. Robinson
Patrice Rodien
Yann Godbert
Christelle De La Fouchardiere
Kate Newbold
Christopher M. Nutting
Soamnauth Misir
Ran Xie
Ana Almonte
Weifei Ye
Maria E Cabanillas
Show All
Source
Cite
Save
Citations (2)
MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)
2020
Journal of the Endocrine Society
Lori J. Wirth
Marcia S. Brose
Eric J. Sherman
Soamnauth Misir
Sharon Xie
Ana Almonte
Weifei Ye
Lisa Licitra
Martin Schlumberger
Steven I. Sherman
Maria E Cabanillas
Show All
Source
Cite
Save
Citations (2)
Phase 2 study of eribulin mesylate administered biweekly in patients with human epidermal growth factor receptor-2–negative metastatic breast cancer
2019
Clinical Breast Cancer
John W. Smith
Amy Irwin
Lori Jensen
Karen L. Tedesco
Soamnauth Misir
Wei Zhu
Ana Almonte
Yaohua He
Ran Xie
Martin Olivo
Joyce O'Shaughnessy
Show All
Source
Cite
Save
Citations (3)
1